Microblate Flex News Today

Lung cancer can now be diagnosed and treated at the same time using a new type of robotic surgery. Margaret Kirkham, 77, was the first patient in the world to have the procedure, as she tells ADRIAN MONTI.

Creo Medical Group PLC on Thursday said the National Institute for Health & Care Excellence in the UK has selected its Speedboat Inject product for assessment. The Chepstow, Wales-based medical... | June 1, 2023

<iframe src=https://www.youtube.com/embed/MKvy9QsWtIg title=Creo Medical Group PLC CEO Craig Gulliford speaks to Thomas Warner from Proactive after announcing the successful completion of a first... | May 26, 2023

Creo Medical Group PLC (AIM:CREO) CEO Craig Gulliford speaks to Thomas Warner from Proactive after announcing the successful completion of a first human...

Creo Medical Group PLC on Tuesday said that it has reached its first in-human milestone for MicroBlate Flex, as part of a Lung Tissue ablation clinical study. Creo Medical is a Chepstow, Wales-based... | May 23, 2023

Creo Medical Group PLC (AIM:CREO) has described as a landmark moment the successful completion of a first human trial of its pioneering MicroBlate Flex...

We know what weve got to do. These are the words of Creo Medical boss following what he described as the Wales-based medical device companys final fundraising round.

“We know what weve got to do.” These are the words of Creo Medical Group PLC (AIM:CREO) chief executive Craig Gulliford following what he described as the...

We know what weve got to do. These are the words of Creo Medical boss following what he described as the Wales-based medical device companys final fundraising round.

Creo Medical Limited (LON:CREO – Get Rating) insider Charles Spicer acquired 15,435 shares of the firm’s stock in a transaction on Thursday, May 26th. The shares were acquired at an average price of GBX 97 ($1.22) per share, with a total value of £14,971.95 ($18,839.75). Shares of LON CREO opened at GBX 97.50 ($1.23) on […]